Golden Valley Development, Inc (GVDI)

USD 0.04

(0.0%)

Operating Expenses Summary of Golden Valley Development, Inc

  • Golden Valley Development, Inc's latest annual operating expenses in 2023 was 141.81 Thousand USD , up 28.92% from previous year.
  • Golden Valley Development, Inc's latest quarterly operating expenses in 2024 Q1 was 36.89 Thousand USD , up 4.96% from previous quarter.
  • Golden Valley Development, Inc reported a annual operating expenses of 110 Thousand USD in annual operating expenses 2022, down 0.0% from previous year.
  • Golden Valley Development, Inc reported a annual operating expenses of - USD in annual operating expenses 2021, down 0.0% from previous year.
  • Golden Valley Development, Inc reported a quarterly operating expenses of 36.89 Thousand USD for 2024 Q1, up 4.96% from previous quarter.
  • Golden Valley Development, Inc reported a quarterly operating expenses of 35.15 Thousand USD for 2023 Q4, down -4.09% from previous quarter.

Annual Operating Expenses Chart of Golden Valley Development, Inc (2023 - 2004)

Created with Highcharts 11.1.0YearsOperating Expenses2004200620082010201220142016201820202022-1000000 USD0 USD1000000 USD2000000 USD3000000 USD4000000 USD5000000 USD

Historical Annual Operating Expenses of Golden Valley Development, Inc (2023 - 2004)

Year Operating Expenses Operating Expenses Growth
2023 141.81 Thousand USD 28.92%
2022 110 Thousand USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2015 3.97 Million USD 183.91%
2014 1.39 Million USD 24460.15%
2013 5696.00 USD 0.0%
2011 -73.89 Thousand USD -209.38%
2010 67.55 Thousand USD -62.86%
2009 181.87 Thousand USD 649.25%
2008 24.27 Thousand USD -37.68%
2007 38.95 Thousand USD 43.42%
2006 27.15 Thousand USD 96.73%
2005 13.8 Thousand USD 1625.63%
2004 800.00 USD 0.0%

Peer Operating Expenses Comparison of Golden Valley Development, Inc

Name Operating Expenses Operating Expenses Difference
American Medical Technologies Inc. 2.86 Million USD 95.047%
Ansell Limited 495.5 Million USD 99.971%
Ansell Limited 495.5 Million USD 99.971%
BG Medicine, Inc. - USD -Infinity%
Biotage AB (publ) 82.8 Million USD 99.829%
BioLife Sciences Inc. - USD -Infinity%
CB Scientific, Inc. 1.73 Million USD 91.806%
Psykey, Inc. 1.21 Million USD 88.314%
ConvaTec Group Plc 910.31 Million USD 99.984%
ConvaTec Group Plc 872.5 Million USD 99.984%
Encision Inc. 3.77 Million USD 96.245%
Hear AtLast Holdings, Inc. 109.93 Thousand USD -29.0%
Innovative MedTech Inc. 6.09 Million USD 97.675%
LifePoint, Inc. 7.42 Million USD 98.09%
Medite Cancer Diagnostics, Inc. 6.34 Million USD 97.766%
Paradigm Medical Industries, Inc. 855 Thousand USD 83.414%
QuantRx Biomedical Corporation - USD -Infinity%
Remedent, Inc. 726.13 Thousand USD 80.47%
Reflect Scientific, Inc. 1.06 Million USD 86.668%
SmileDirectClub, Inc. 517 Million USD 99.973%
Sector 10, Inc. 39.84 Thousand USD -255.916%
Shandong Weigao Group Medical Polymer Company Limited 6.64 Billion USD 99.998%
SheerVision, Inc. 2.33 Million USD 93.918%
United Health Products, Inc. 2.42 Million USD 94.156%
Vasamed, Inc. 4.67 Million USD 96.965%
Wearable Health Solutions, Inc. 2.56 Million USD 94.464%
Yubo International Biotech Limited 1.25 Million USD 88.726%